Stocks · Health care · Pharmaceutical Preparations

Arcus Biosciences, Inc.

RCUS Clue Score44
United States Fiscal year ends December CIK 0001724521 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$11.43M
$10.34M on a plan · $1.09M straight out of an exercise
Sold at will
$0.00
0 of 36 sales
Net
−$11.43M
$0.00 against sales at will